Insight Genetics Awarded Phase I SBIR Contract
Insight Genetics has been awarded a $200,000 Phase I Small Business Innovation Research contract from the National Cancer Institute.
Read MoreSearch Results for: lung cancer
Presenters Discuss Oncimmune Blood Test at CHEST
Two oral presentations and five poster presentations during CHEST 2010 will collectively highlight the clinical and economic benefits of Oncimmune’s EarlyCDT-Lung.
Read MoreRPC, Provista Sign 5-Year Laboratory Services Agreement
Radient Pharmaceuticals Corporation has entered into an exclusive 5-year laboratory services agreement with Provista Diagnostics Inc.
Read MoreRadient Pharmaceuticals Announces Its 2010 Onko-Sure Reference Guide
Radient Pharmaceuticals Corp (RPC) announced broad availability of its 2010 Onko-Sure Reference Guide for the Company’s USFDA-approved Onko-Sure in vitro diagnostic (IVD) cancer test kit.
Read More
Oncology Testing: Becoming More Effective, Specific, and Predictive
Advances in genomics and biomarker identification facilitate more accurate diagnoses for cancer patients.
Read More